Jeremy Bastid
Provepharm obtains B Corp™ certification
© Yann Bouvier
Cell-Easy and Toulouse University Hospital obtain IMPD approval for first-in-human clinical trial in systemic sclerosis, using promising allogeneic approach
© Cell-Easy
Orphelia Pharma files EU marketing authorization application for KIZFIZO®
CardioRenal receives FDA Breakthrough Device Designation for TENOR
© CardioRenal
Carthera announces positive outcome of End-of-Phase 2 meeting with FDA for SonoCloud-9 system for treatment of recurrent glioblastoma
Genoscience Pharma receives FDA Orphan Drug Designation for ezurpimtrostat to treat HepatoCellular Carcinoma (HCC)
Isorg’s FAP30 optical fingerprint sensor obtains FBI certification
Provepharm receives FDA marketing approval in US for BLUDIGO, its indigo carmine injection drug product
